Printer Friendly

H. STEWART PARKER - TARGETED GENETICS CORPORATION (TGEN).

(HAU611) H. STEWART PARKER, CEO of TARGETED GENETICS CORPORATION (TGEN), describes the company's business and its background; prospects for the industry, with positive and negative trends; competitive threats; strategic opportunities for the firm including its marketing plans and acquisition potential; management strength and organization; and the financial prospects of the firm looking forward. TARGETED GENETICS CORPORATION (TGEN) is in the BIOTECHNOLOGY industry. Published date 11/01/99. Complete text approximately 3000 words. Document # HAU611. CEO INTERVIEWS, The Wall Street Transcript, 100 Wall Street, NY 10005. Voice (212) 952 7400. Fax: (212) 668-9842. E-mail: transcript@twst.com.

Copyright 1999 Wall Street Transcript Corporation
COPYRIGHT 1999 Wall Street Transcript Corporation
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1999 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Comment:H. STEWART PARKER - TARGETED GENETICS CORPORATION (TGEN).
Publication:Wall Street Transcript Digest
Geographic Code:1USA
Date:Nov 1, 1999
Words:102
Previous Article:OUTLOOK FOR BIOTECHNOLOGY - PETER F. DRAKE.
Next Article:SAM A. BROOKS - RENAL CARE GROUP INC (RCGI).
Topics:


Related Articles
H. STEWART PARKER - TARGETED GENETICS CORPORATION (TGEN).
American Home and Targeted Genetics establish partnership for B-domain deleted factor VIII hemophilia gene Therapy.
TARGETED GENETICS GETS GENE THERAPY PATENT FOR CHOLESTEROL.
CEO INTERVIEW: H.STEWART PARKER - TARGETED GENETICS CORPORATION (TGEN).
CEO INTERVIEW: TODD SIMPSON - TARGETED GENETICS CORPORATION (TGEN).

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters